Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Nature Communications
|
September 22, 2020
Whole genome analysis of water buffalo and global cattle breeds highlights convergent signatures of domestication
Prasun Dutta, Andrea Talenti, Rachel Young, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 20, 2015
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Andrew C Harris, Rachel Young, Steven Devine, et al.
Blood Advances
|
April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Transplantation and Cellular Therapy
|
March 28, 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
Muna Qayed, Urvi Kapoor, Scott Gillespie, et al.
Blood
|
September 12, 2022
Effective treatment of low-risk acute GVHD with itacitinib monotherapy
Aaron Etra, Alexandra Capellini, Amin Alousi, et al.
Transplantation and Cellular Therapy
|
September 2, 2021
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
Makda Getachew Zewde, George Morales, Isha Gandhi, et al.
Blood Immunology & Cellular Therapy
|
May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM
Yu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Transplantation and Cellular Therapy
|
December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Blood Advances
|
December 22, 2020
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
Stephanie C Gergoudis, Zachariah DeFilipp, Umut Özbek, et al.
Blood Advances
|
May 4, 2023
The utility of biomarkers in acute GVHD prognostication
Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Nature Communications
|
September 22, 2020
Whole genome analysis of water buffalo and global cattle breeds highlights convergent signatures of domestication
Prasun Dutta, Andrea Talenti, Rachel Young, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 20, 2015
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Andrew C Harris, Rachel Young, Steven Devine, et al.
Blood Advances
|
April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Zachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Transplantation and Cellular Therapy
|
March 28, 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD
Muna Qayed, Urvi Kapoor, Scott Gillespie, et al.
Blood
|
September 12, 2022
Effective treatment of low-risk acute GVHD with itacitinib monotherapy
Aaron Etra, Alexandra Capellini, Amin Alousi, et al.
Transplantation and Cellular Therapy
|
September 2, 2021
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
Makda Getachew Zewde, George Morales, Isha Gandhi, et al.
Blood Immunology & Cellular Therapy
|
May 15, 2026
Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM
Yu Akahoshi, Nikolaos Katsivelos, Ioannis E Louloudis, et al.
Transplantation and Cellular Therapy
|
December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Blood Advances
|
December 22, 2020
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
Stephanie C Gergoudis, Zachariah DeFilipp, Umut Özbek, et al.
Blood Advances
|
May 4, 2023
The utility of biomarkers in acute GVHD prognostication
Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, et al.
Page
of 9